Acucela Inc., of Seattle, named George Lasezkay executive vice president, legal affairs.
Adare Pharmaceuticals Inc., of Princeton, N.J., named Joseph (Joe) Del Buono vice president, finance and chief financial officer.
Amag Pharmaceuticals Inc., of Waltham, Mass., appointed Joseph Vittiglio senior vice president, general counsel and secretary.
Celator Pharmaceuticals Inc., of Ewing, N.J., named Michael R. Dougherty executive chairman of its board.
Chiasma Inc., of Newton, Mass., appointed William H. Ludlam vice president of medical affairs.
Cytomx Therapeutics Inc., of South San Francisco, appointed Rachel Humphrey chief medical officer.
Halozyme Therapeutics Inc., of San Diego, appointed Michael J. LaBarre chief scientific officer, and named Michael Shepard a research fellow.
Inmed Pharmaceuticals Inc., of Vancouver, British Columbia, added Paul Brennan to its board.
Oncosec Medical Inc., of San Diego, named Sheela Mohan-Peterson chief legal and compliance officer.
Regulus Therapeutics Inc., of La Jolla, Calif., appointed Michael Huang vice president, clinical development.
Valeant Pharmaceuticals International Inc., of Laval, Quebec, added D. Robert Hale to its board.